Multi-center, blinded, randomized, PaRallEl-group, Phase 3 study with aproCltentan in Subjects with Resistant HypertensiON (RHT)

  • Biswas, Sinjini, (Primary Chief Investigator (PCI))
  • Reid, Christopher (Associate Investigator (AI))
  • Steer, Caroline, (Associate Investigator (AI))
  • Ajani, Andrew (Associate Investigator (AI))

Project: Research

Short titleThe Precision Study
StatusFinished
Effective start/end date26/11/1830/04/19